Sweden
· Delayed Price · Currency is SEK Q-linea AB Company Description
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, European Union, the Middle East, and the United States.
It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert.
The company also develops Podler, a portable blood culture unit for incubating and detecting growth in blood bottles.
It serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
| Country | Sweden |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 94 |
| CEO | Stuart Gander |
Contact Details
Address: Dag Hammarskjölds väg 52 A Uppsala, 752 37 Sweden | |
| Phone | 46 18 444 3610 |
| Website | qlinea.com |
Stock Details
| Ticker Symbol | QLINEA |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0011527845 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stuart Gander | Chief Executive Officer |
| Anders Ljunggren | MD and Deputy Chief Executive Officer |
| Christer Samuelsson | Chief Financial Officer and IR |
| Henrik Jacobson | Chief Operating Officer |
| Natalie Brown | Director of Global Marketing |
| Ulrika Stolpe | HR Manager |
| Jonas Melin | Director Product Development |
| Thomas Fritz | Chief Commercial Officer |
| Victoria Lerneryd | Manager of QA/RA |